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ABSTRACT Structural rearrangements of the myosin upper-50 kD subdomain are thought to play a key role in coordinating
actin binding with nucleotide hydrolysis during the myosin ATPase cycle. Such rearrangements could open and close the active
site in opposition to the actin-binding cleft, helping explain the opposing afﬁnities of myosin for actin and nucleotide. To directly
examine conformational changes across the active site during the ATPase cycle we have genetically engineered a mutant of
chicken smooth-muscle myosin, F344W motor domain essential light chain, which contains a single tryptophan (344W) located
on a short loop between two alpha helixes that traverse the upper-50 kD subdomain in front of the active site. Fluorescence
resonance energy transfer was examined between the 344W donor probe and 29(39)-O-(N-methylanthraniloyl) (mant)-
nucleotide acceptor probes in the active site of this construct. The observed ﬂuorescence resonance energy transfer
efﬁciencies were 6.4% in the presence of mant ADP and 23.8% in the presence of mant ATP, corresponding to distances of
33.4 A˚ and 24.9 A˚, respectively. Our results are consistent with structural rearrangements in which there is an 8.5-A˚ closure
between the 344W residue and the mant moiety during the transition from the strongly (ADP) to weakly (ATP) actin-bound
states of the myosin ATPase cycle.
INTRODUCTION
Muscle contraction is driven by cyclical interactions between
the myosin II motor protein and ﬁlamentous actin. To fulﬁll
its motor function myosin must hydrolyze nucleotide and
then undergo a conformational change, the power stroke, to
release the stored energy to create force and movement.
Myosin coordinates its power stroke with binding to and
releasing from actin, a process thought to be mediated by the
occupancy of its active site. Thus the ATPase cycle acts as an
internal clock timing myosin’s rearrangements such that the
energy released by hydrolysis is harnessed as directed
motion. A simple version of the myosin ATPase cycle is
shown below (Scheme 1),
where A ¼ actin, M ¼ myosin, AM ¼ the acto-myosin
complex, and Pi ¼ inorganic phosphate (1).
From the strongly actin-bound AM rigor complex, myosin
binds tightly to ATP causing a decrease in its afﬁnity for actin
by .4 orders of magnitude, triggering actin release. After
ATP hydrolysis, Pi release is thought to result in a conforma-
tional change in which myosin increases its afﬁnity for actin
from micromolar to nanomolar and initiates its power stroke.
Myosin remains strongly bound to actin after ADP release,
until a new molecule of ATP binds at the active site. To avoid
confusion, we will refer to myosin as being strongly bound to
actin but tightly bound to ATP throughout the text. Myosin
has a high afﬁnity for actin in the apo and ADP states (even in
the absence of actin) and thus we will refer to these as strong-
binding states throughout the text.
A wealth of myosin II crystal structures, solved in the
absence of nucleotide and in the presence of nucleotides
and nucleotide analogs (2–7), have allowed assignment of
force production, actin binding, and nucleotide hydrolysis to
speciﬁc structural domains (Fig. 1). The myosin force-
generation function is thought to be provided by a lever-arm
domain (residues 781–820), which has been observed in
numerous positions in crystal structures of myosin. It has
been proposed that the various positions all correlate to one
of two conformational classes, either a pre-power stroke state
in which the lever arm is tilted up relative to the core domain
or a post-power stroke ‘‘near-rigor’’ state in which the lever
arm is pointed down (8).
The actin-binding site of myosin is deﬁned by a large cleft
that divides the catalytic domain into the so-called upper-
and lower-50-kD subdomains. Limited movement of the
actin-binding cleft has been observed by comparing myosin
crystal structures in various states of the ATPase cycle,
although the cleft does actually close somewhat in the recent
myosin V apo structure (9) and undergoes some rearrange-
ments in the recent myosin II apo structure of Reubold et al.
(8). As myosin V binding to actin is diffusion-limited, it has
been suggested that the myosin V actin-binding cleft is
already closed in the apo state in the absence of actin, making
myosin V an instructive special case. Fitting skeletal and
smooth-muscle myosin crystal structures into cryoelectron
microscopy (cryo-EM) density maps of S1-decorated actin
ﬁlaments predicts a greater closing of the actin-binding cleft
in the posthydrolysis state than is seen in any of the crystal
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structures (10,11). In fact, rotation of the upper- and lower-
50-kD subdomains is seen in the recent myosin apo
structures. For chicken smooth-muscle myosin II, a solution
study using an intrinsic tryptophan probe located in the 50-kD
cleft showed that actin-binding and closure of the actin-
binding cleft occur at nearly identical rates (12). Fluores-
cence data from this study suggested cleft closure in strongly
actin-bound states even in the absence of actin. This data
supports a model of the transition from the weakly to the
strongly actin-bound state in which the sum of many small
attractions between myosin and actin produces movement
of the upper-50-kD domain, culminating in cleft closure.
Similarly, a study of Dictyostelium myosin II using extrinsic
probes demonstrated that cleft movement is linked to actin
binding (13). Thus, a growing body of evidence suggests that
the actin-binding cleft begins to close in strong-binding
states of the ATPase cycle even in the absence of actin, and
closes to a greater degree upon actin binding.
Although domain movements of the lever arm and actin-
binding cleft are now well established in myosin, confor-
mational changes at the active site have proven difﬁcult to
observe by crystallography. The active site would be ex-
pected to open in the strongly actin-bound states to allow for
the exchange of ADP and ATP, and close upon ATP binding
to provide a catalytically competent conformation for
hydrolysis. Rayment et al. predicted from their original
myosin crystal structure that opening of the active site could
be triggered by actin-binding cleft closure (14). Further,
pivoting the upper-50-kD subdomain around a hinge located
near the active site allows for greatly improved ﬁtting of the
skeletal myosin crystal structure to cryo-EM reconstructions
of the acto-myosin complex (11). Such a pivot would close
the actin-binding cleft while opening the active site, as
predicted by Rayment et al. (14).
The myosin active site, considered from a perspective
closer to the g-phosphate binding pocket, contains several
loop motifs in common with the members of the kinesin and
G-protein superfamilies of nucleotide triphosphate-binding
proteins (15). Three loops, termed the phosphate-binding
loop (P-loop), switch I, and switch II, are thought to play
coordinating roles during the hydrolysis cycle. However,
aside from these similarities, large structural differences
exist between the active sites of G-proteins, kinesins, and
myosins. The switch I and switch II loops are exposed in
G-proteins and have been shown to participate directly in
binding to G-protein targets (16–18); e.g., switch II of the
a-subunit of heterotrimeric G-proteins interacts directly with
its bg subunits and switch I of the Rap-1 G-protein inter-
acts with its target Raf. In contrast, in the much larger and
more complex myosins, the switches are buried and are
not involved in interactions with actin but instead act to
coordinate the distal domains that carry out myosin function.
Although crystal structures have been obtained for a large
variety of G-proteins in all stages of the hydrolysis cycle, in
myosin the structural picture is incomplete, as only the
weakly actin-bound states have been captured. This may be
a consequence of the complexity of myosin active sites
relative to those of G-proteins. Even comparing myosins to
the closely related kinesins, elements of the active site are
thought to act by somewhat different mechanisms, e.g.,
strong binding of myosin to actin and kinesin to micro-
tubules don’t occur in identical nucleotide states. Further,
whereas switch I has been shown to close on microtubule
binding for kinesins (16), for myosins there is reason to
believe that the opposite occurs, as actin binding may trigger
opening of switch I (8,11). Thus, despite information about
hydrolysis mechanisms in G-proteins and kinesins, the
question of how the myosin active site is altered during the
ATPase cycle remains open and controversial. Of particular
importance is the question of whether structural events at the
myosin active site required for enzymatic function can be
accommodated solely by rearrangements of the P-loop,
switch I, and switch II, or must include more global changes.
In this study, ﬂuorescence resonance energy transfer (FRET)
is used to examine distance changes across the active site in
nucleotide states that correspond to both strongly and weakly
actin-bound states. A chicken smooth-muscle myosin frag-
ment, F344Wmotor domain essential light chain (MDE), has
been genetically engineered to contain a single tryptophan
(W344) that acts as the FRET donor in this study, whereas
29(39)-O-(N-methylanthraniloyl) (mant) ﬂuorescent analogs
of ATP and ADP bound to the active site are used as FRET
acceptors. The single tryptophan substitution (F344W) is
located on a loop between two a-helixes that traverse the
myosin upper-50-kD subdomain at the front of the active site,
whereas the mant moiety of the nucleotide analogs is known
to sit in the nucleotide binding pocket (Fig. 1). Measurements
FIGURE 1 Structure of F344W-MDE with the mant nucleotide (cyan)
and the 344W residue shown as a ball-and-stick representation (green). Also
highlighted are the essential light chain (ELC, blue) and the switch I, switch
II, and P-loop (red). The chicken smooth-muscle myosin MDE structure
(1BR4.pdb (2)) was superimposed with mant ADP coordinates (1LVK.pdb
(4)), and a distance of 22.4 A˚ was measured between 344W and the mant
moiety. This ﬁgure was prepared in Swiss PDB Viewer (GlaxoSmithKline).
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made from superimposed crystal structures of Dictyostelium
myosin II bound to mant nucleotides (4) and chicken smooth-
muscle myosin bound to ADP-AlF4 (2) show that the 344W
residue is located;22 A˚ from themantmoiety, placing itwithin
the useful range of measurement for this FRET donor-acceptor
pair. Correlation of FRET efﬁciency with distance in each
nucleotide state has allowed us tomonitor a structural rearrange-
ment of the active site that is consistent with the predictions of
both Rayment et al. (14) and Holmes et al. (11).
MATERIALS AND METHODS
Chemicals
Mant-labeled ATP and ADP were purchased from Molecular Probes
(Eugene, OR). ATP and ADP were purchased from Sigma (St. Louis, MO).
All other reagents were of the highest quality available.
Solutions
The standard buffer for ﬂuorescence procedures was a 3-[N-morpholino]
propanesulfonic acid (MOPS) buffer at pH 7.4 (20 mMMOPS, 20 mMKCl,
1 mM EGTA, 1 mM NaN3, 1 mM dithiothreotol, and 2 mMMgCl2) at room
temperature. For protein puriﬁcation procedures an imidazole buffer at
pH 7.4 (10 mM imidazole-HCl, 90 mM NaCl, 1 mM NaN3, and 1 mM
dithiothreotol) was used at 4C.
cDNA construction
Site-directed mutagenesis was performed using a Quik-Change mutagenesis
kit (Stratagene, LaJolla, CA) to create a mutant cDNA coding for a chicken
smooth-muscle myosin heavy chain containing a single nonendogenous
tryptophan at position 344 (highlighted as a space-ﬁlling model; Fig. 1). The
cDNA used as a template (null-MDE) was a clone coding for the heavy
chain containing the motor domain and light-chain binding regions (residues
1–819 kindly provided by Kathleen M. Trybus, University of Vermont) in
which the seven endogenous tryptophans of the clone were mutated to
phenylalanine (or methionine in the case of Trp-546) as previously described
(19). The FLAG epitope (DYKDDDK) was attached to the C-terminus of
the cDNA for puriﬁcation purposes.
Protein expression and puriﬁcation
The F344W-MDE and tryptophan null-MDE constructs were expressed in
baculovirus by coinfecting Sf-9 cells with recombinant baculoviruses
containing the mutant heavy chain and the essential light chain. Cells were
incubated with baculovirus for 3 days, lysed, fractionated between 30% and
70% saturated ammonium sulfate and dialyzed overnight in imidazole buffer
at 4C as previously described (19). The resulting lysate was puriﬁed on an
anti-FLAG antibody column, dialyzed overnight into MOPS buffer, and
assayed for purity by SDS page on a Coomassie-stained gel (20). Protein
concentrations were determined by the method of Edelhoch (21). Fluo-
rescence experiments were performed on 10 such preparations of F344W-
MDE. Actin used in actin-activated ATPase assays was puriﬁed from
acetone powder as previously described (22). The puriﬁed actin concen-
tration was determined spectroscopically using an extinction coefﬁcient
of 0.63 mg ml1 cm1 at 290 nm.
Enzymatic assays
Actin-activated ATPase assays were performed as previously described (23)
at 37C in low ionic strength MOPS buffer (10 mM MOPS, 1 mM EGTA,
and 7 mM MgCl2) at pH 7.0 using a range of actin concentrations between
0 and 136 mM. ATPase rates were plotted as a function of actin con-
centration and ﬁt to the Michaelis-Menten equation using a nonlinear least-
squares routine in SigmaPlot 8.0 (SPSS, Chicago, IL) to determine values
of Vmax and Km.
Steady-state ﬂuorescence measurements
Steady-state ﬂuorescence measurements of tryptophan ﬂuorescence were
obtained on a Quantamaster ﬂuorimeter (Photon Technology International,
South Brunswick, NJ) equipped with a 50-W xenon arc lamp excitation
source, excitation/emission monochrometers, and aWG-320 cutoff emission
ﬁlter. Protein samples were excited at 295 nm and tryptophan emission
spectra were collected from 305 to 400 nm. Slit widths of 1 nm (excitation)
and 5 nm (emission) were used. All spectra were corrected for Raman scatter
and background ﬂuorescence by subtraction of an appropriate buffer blank.
Spectra were taken at a protein concentration of 1 mM in the standard MOPS
buffer (deﬁned above) at room temperature. Spectra of protein plus ATP or
ADP were obtained at a saturating nucleotide concentration of 2 mM. Mant
ATP and mant ADP were used at nonsaturating concentrations of 15 mM
and 10 mM, respectively, to avoid inner-ﬁlter effects associated with the
mant moiety. F344W-MDE plus mant nucleotide spectra were corrected for
nonsaturating concentrations of mant nucleotides using
Fb ¼ ðFT1 ðFubð1 fbÞÞÞ=ðfbÞ; (1)
where FT ¼ total ﬂuorescence, Fb ¼ ﬂuorescence of 344W in the nucleotide-
bound state, fb ¼ fraction of F344W-MDE bound to nucleotide, and Fub ¼
ﬂuorescence of 344W in the absence of nucleotide. Fb was determined by
solving 0 ¼ f 2b  ð½Ei1 ½Si1KdÞ fb1 ½Ei½Si for fb, where [Ei] ¼ initial
protein concentration [Si] ¼ initial nucleotide concentration, and Kd ¼ the
dissociation constant for nucleotide binding to F344W-MDE. Kd values
were determined as discussed below. Quantum yields for tryptophan were
calculated by comparison to an L-tryptophan standard (v ¼ 0.14) as
previously described (24).
Fluorescence lifetime measurements
Lifetime measurements were made using a Photon Technology International
(London, Ontario, Canada) Laserstrobe instrument. The excitation source
for lifetime experiments was a nitrogen-pumped dye laser. Exciting radiation
at 590 nm from the laser was modiﬁed to the ﬁnal 295 nm using a frequency
doubler, and ﬂuorescence was collected by a time-delay gated photo-
multiplier tube. The instrument response function at 295 nm was determined
using a dilute solution of nonfat dry milk as a scatterer. The F344W-MDE
decays were deconvoluted from the instrument response function and ﬁt
to a two-exponential decay using FeliX 32 software provided by Photon
Technology International.
Acrylamide quenching experiments
To determine the degree of exposure of the 344W residue to solvent,
acrylamide quenching experiments were performed in various nucleotide
conditions, including the presence of 2 mM ATP or 2 mM ADP, or in the
apo state. The ﬂuorescence values from the 333 nm emission peak in the
absence of quencher (F0) were divided by the ﬂuorescence in the presence
of quencher (F), plotted against quencher concentration (Q), and ﬁt to the
Stern-Volmer equation using linear regression analysis in Kaleidagraph
(Synergy Software, Reading, PA):
F0=F ¼ 11Ksv½Q ¼ 11 kqt0½Q; (2)
where kq is the bimolecular quenching constant, t0 is the 344W tryptophan
lifetime in the absence of quencher, and Ksv is the Stern-Volmer constant
(25). Thus, kq was calculated by dividing Ksv by t0, determined by ﬂuo-
rescence lifetime measurements.
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Fluorescence resonance energy transfer
The distance between the 344W donor and mant acceptor probes was mea-
sured using FRET according to the Fo¨rster energy transfer theory (26). We
measured the efﬁciency (E) of FRET by observing the decrease in ﬂuo-
rescence of the 344W donor:
E ¼ 1 ðFDAmant-nucleotide=FDnucleotideÞ; (3)
where FDA mant-nucleotide is the tryptophan ﬂuorescence of the F344 donor at
333nm in the presence of mant ATP or mant ADP nucleotide and FD
nucleotide is the tryptophan ﬂuorescence of the F344 donor at 333 nm in the
presence of unlabeled ATP or ADP. All ﬂuorescence values were corrected
for the fraction of protein bound to nucleotide as described above. Fluo-
rescence from the endogenous tyrosines in the 344W construct was cor-
rected for by subtraction of values in the corresponding nucleotide states
obtained for the null-MDE control containing no tryptophan residues.
The distance (r) between the donor and acceptor probes was determined
by Eq. 4:
r ¼ R0ðE1  1Þ1=6 A˚; (4)
where R0 is the Fo¨rster distance at which E ¼ 50%.
R0 was calculated using Eq. 5:
R0 ¼ 9:793 103ðK2JQDn4Þ1=6 A˚; (5)
where n is the refractive index of the buffer (assumed to be 1.4), QD is the
quantum yield of 344W in the presence of ADP, mant ADP, ATP, and mant
ATP (0.11, 0.10, 0.11, and 0.08, respectively), K2 is an orientation factor for
which we assumed a value of 2/3 consistent with free rotation of the donor
and acceptor probes, and J is the spectral overlap between the donor emis-
sion and acceptor excitation given by Eq. 6:
J ¼
Z
FDðlÞeAðlÞl4dl; (6)
where l is the wavelength, FD is the normalized intensity of the unquenched
donor, and eA is the extinction coefﬁcient of the acceptor. J was determined
to be 6.063 1015 M1 cm3 by numerical integration of our experimentally
determined FD and eA values at 1-nm intervals for F344W-MDE in the
presence of both mant ATP and mant ADP.
Equilibrium nucleotide binding
afﬁnity measurements
To determine F344W-MDE-mant ADP afﬁnity by steady-state ﬂuorescence,
the protein was titrated with increasing concentrations of nucleotide in a
series and the decrease in tryptophan ﬂuorescence emission at 333 nm was
monitored in the ﬂuorimeter after excitation at 295 nm. These ﬂuorescence
values were corrected for inner-ﬁlter and dilution effects, normalized to the
ﬂuorescence value obtained for nucleotide-free protein and subtracted from
1. Plotting (1 normalized ﬂuorescence) versus [mant nucleotide] produces
a rectangular hyperbola which approaches a maximum binding value (Bmax)
asymptotically:
ð1 normalized fluorescenceÞ ¼
½mant nucleotide=ðKd1 ½mant nucleotideÞ: (7)
The resulting plots were used to determine dissociation constant (Kd)
values (equal to the nucleotide concentration at which 0.5Bmax occurs) by
ﬁtting Eq. 7 to the data using SigmaPlot 8.0 (SPSS Corp., Chicago, IL). The
afﬁnity of the F344W-MDE protein for mant ATP was determined similarly
by exciting at 295 nm and after both the tryptophan emission at 333 nm and
the mant ATP ﬂuorescence emission at 440 nm (in separate experiments).
Unlike the case for mant ADP, these titrations could not be performed in a
continuous series due to ATP hydrolysis during the experiments. Therefore,
each speciﬁc concentration of mant ATP was added to protein and ﬂuo-
rescence at 333 nm was monitored in the ﬂuorimeter as a function of time.
Transient kinetic analysis of mant-ADP binding
The afﬁnity of F344W-MDE for mant ADP was also determined by making
stopped-ﬂow measurements of the binding and release rates of mant ADP,
where Kd ¼ koff/kon. To measure the apparent second-order binding constant
(kon) for mant ADP, 2 mM F344W-MDE in one syringe was rapidly mixed
with various concentrations of mant ADP (0.3–5 mM) in the second syringe.
To determine the rate of mant ADP release (koff) from F344W-MDE, chase
experiments were performed in which a complex of mant ADP (10 mM)
bound to 2 mM F344W-MDE in one syringe was rapidly mixed with an
excess of ATP (500 mM) in the second syringe. The rate of mant ADP
binding or release was determined by following the change in mant ADP
ﬂuorescence above 420 nm with a 420 cutoff ﬁlter after excitation at 295 nm
(5-nm bandpass). All transient kinetic experiments were done using a
BioLogic mSFM-20 stopped-ﬂow instrument (Claix, France) with a dead
time of 2.1 ms under the ﬂow-rate conditions used. The resulting data were
ﬁt using nonlinear regression analysis in Kaleidagraph (Synergy Software,
Reading, Pa.). Experiments were performed in the MOPS buffer as de-
scribed above for steady-state ﬂuorescence experiments at 25C.
Protein structural comparisons
The three-dimensional structures of myosin isoforms were superimposed
and visualized in Swiss-PdbViewer (GlaxoSmithKline, Middlesex, UK).
RESULTS
Actin-activated ATPase assays
ATPase assays performed on the F344W-MDE protein
(Table 1) demonstrated that the conservative F344W muta-
tion did not adversely affect the ability of the mutant protein
to interact with actin or hydrolyze nucleotide. Compared to
WT-MDE protein, F344W-MDE had a threefold lower
Vmax value (0.23 s
1 vs. 0.76 s1), but a .4 times higher
basal rate of hydrolysis in the absence of actin (0.35 s1 vs.
0.08 s1). However, because the mutant protein also had a
fourfold tighter Km value for actin (15 mM vs. 62 mM), the
ratio of Vmax to Km of F344W-MDE was slightly higher
than that of WT-MDE (1.5 3 104 M1 s1 vs. 1.2 3 104
M1 s1). Similar results, i.e., lower Vmax and lowerKm values
for the mutant protein versus the wild-type, have been ob-
tained for several other single-tryptophan mutants of myosin
created in our lab (19,27). Thus, the F344W-MDE protein
behaves much like other single-tryptophan MDE mutant
proteins and the wild-type chicken smooth-muscle MDE
TABLE 1 Kinetic parameters of MDE constructs
MDE construct KM (mM)* Vmax (s
1)* Vmax/KM (mM
1 s1)
WT-MDE 62 0.74 1.2 3 104
F-344W-MDE 15 0.23 1.5 3 104
*Km and Vmax averaged values were determined from two separate protein
preparations assuming Michaelis-Menten kinetics by plotting actin-
activated ATPase rates versus actin concentration for 23, 46, 92, 115,
and 136 mM actin at 37C.
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protein in terms of its ability to hydrolyze ATP in an efﬁcient
and actin-dependent manner.
Steady-state ﬂuorescence in the absence of FRET
To characterize the tryptophan donor signal in the absence of
acceptor, we examined the steady-state ﬂuorescence emis-
sion spectra of the F344W-MDE protein in the absence of
nucleotide and in the presence of unlabeled ADP and ATP.
In the presence of saturating concentrations of ADP or ATP,
the intrinsic ﬂuorescence of F344W-MDE was quenched
relative to the apo state by 81 6 5% and 76 6 3%,
respectively (Fig. 2 and Table 2), showing that the 344W
residue experiences a different environment in each of these
conditions. Addition of saturating ADP to a solution of
myosin is known to produce a strongly actin-bound myosin
state (28). However, addition of saturating ATP leads to
a more complex situation as hydrolysis of the triphosphate
can occur and thus myosin will be found in a mixture of
nucleotide states with the percentage of myosin in each state
being determined by the rate constants for the protein in the
ATPase cycle, as discussed below. No spectral shift of
the F344W-MDE emission maxima of 333 nm was seen in
the steady-state spectra in the presence of ATP or ADP; the
implications of this are also discussed below.
Acrylamide quenching experiments
To determine the contribution of changes in solvent exposure
to the steady-state spectra of 344W described above, we
performed acrylamide quenching experiments in the apo
state and in the presence of ADP and ATP (Fig. 3). From the
resulting plots of F0/F versus [Q] Stern-Volmer constants of
1.75 6 0.07 M1, 1.65 6 0.07 M1, and 1.45 6 0.21 M1
were determined for the apo, ADP, and ATP conditions,
respectively, by ﬁtting to the Stern-Volmer equation.
Fluorescent lifetime measurements were performed on the
F344W-MDE in the apo state and in the presence of ADP
and ATP, which yielded lifetime values of 3.54 6 0.32 ns,
2.58 6 0.43 ns, and 2.64 6 0.14 ns, respectively (data not
shown). Dividing each Stern-Volmer constant by the
appropriate lifetime yields kq values of 5.1 3 10
8 6 0.1
M1 s1, 5.4 3 108 6 0.3 M1 s1, and 5.7 3 108 6 0.1
M1 s1 for the apo, ADP, and ATP conditions, re-
spectively. Such low bimolecular quenching constant values
are indicative of a highly buried residue, suggesting that
344W remains relatively buried in each nucleotide state
tested. The small variation between these constants shows
that there was little change in the degree of accessibility of
the 344W residue to solvent in the presence of ATP or ADP,
or in the absence of nucleotide.
Afﬁnity determinations for mant nucleotides
Because accurate determination of the afﬁnity of F344W-
MDE for mant nucleotides was so crucial to the accuracy of
the corrected FRET results, the afﬁnities of F344W-MDE for
mant ADP and mant ATP were determined by multiple
methods. Afﬁnity determinations were performed for mant
ATP by following the attenuation of the 344W ﬂuorescent
signal (Fig. 4) and also the enhancement of the mant signal
(data not shown) with respect to nucleotide concentration.
The Kd values of 0.84 6 0.56 mM and 1.24 mM determined
by following the 344W signal and the mant ATP signal,
respectively, were in excellent agreement, suggesting tight
binding of mant ATP to F344W-MDE. The afﬁnity of
F344W-MDE for mant ADP was also determined by
following the attenuation of the 344W ﬂuorescent signal
(Fig. 4), yielding a Kd value of 10.5 mM 6 0.8 mM.
FIGURE 2 Normalized F344W-MDE ﬂuorescence emission spectra in
the presence of (A) ADP (1) and mant ADP (e) or (B) ATP (1) and mant
ATP (e) relative to the apo state (s). Spectra are corrected for the fraction
of F344W-MDE not bound to nucleotide. Quenching of 344W ﬂuorescence
is observed in the presence of each nucleotide: ADP, 81% apo; mant ADP,
76% apo; ATP, 76% apo; mant ATP, 58% apo. Quenching of ﬂuorescence
relative to the apo state in the presence of nucleotides lacking the mant
moiety is due to changes in the 344W environment. Additional loss of
intensity in the presence of mant nucleotides (e.g., mant ATP compared to
ATP or mant ADP compared to ADP) is due directly to FRET between
344W and the mant moiety at the active site.
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However, a signiﬁcant inner ﬁlter effect in the presence
of high concentrations (.12 mM) of mant nucleotides pre-
vented an accurate determination of the saturation level
of mant ADP binding to F344W-MDE. Thus we also de-
termined the afﬁnity of 344W-MDE for mant ADP from
stopped-ﬂow measurements of the reverse and forward
mant ADP binding rates (Fig. 5). We determined an ap-
parent second-order rate constant for binding of mant ADP to
F344W-MDE of 0.79 mM1 s1 and an F344W-MDE-mant
ADP dissociation rate of 6.47 s1 6 0.10 s1. The afﬁnity
of F344W-MDE for mant ADP determined by the ratio of
these rates was 8.26 0.02 mM, in very good agreement with
the 10.5 6 0.8 mM value determined by steady-state ti-
tration. F344W-MDE was determined to be 53 6 2%
saturated in the presence of 10 mM mant ADP using the
Kd of 8.2 mM for mant ADP determined by the kinetic
measurements. In the presence of 15 mMmant ATP F344W-
MDE was determined to be nearly saturated (94 6 1%),
consistent with the steady-state titration data obtained at
concentrations .6 mM. The protein was completely sat-
urated with nucleotide in the presence of 2 mM ATP or ADP
(data not shown).
Steady-state FRET experiments
To determine the distance between 344W at the front of the
active site and the mant moiety on the ribose ring of the
nucleotide sitting at the back of the active site we examined
tryptophan ﬂuorescence in the presence of mant nucleotides
and compared the ﬂuorescence emission to that obtained in
the presence of the unlabeled nucleotides (Fig. 2 and Table
2). Spectra obtained from additions of mant nucleotides to
F344W-MDE showed quenches of intrinsic ﬂuorescence in
the presence of mant ADP and mant ATP of 766 4% and 58
6 4%, respectively, after correction for inner-ﬁlter effects
and fraction of protein bound to nucleotide (Fig. 2). This
additional decrease in ﬂuorescence intensity relative to the
nonmant nucleotides is directly due to resonance energy
transfer from 344W to the mant ﬂuorophore on the ribose
ring of the bound nucleotide. FRET efﬁciencies of 6.4 6
0.4% for mant ADP and 23.8 6 2.3% for mant ATP were
obtained as described in Eq. 3. R0 determinations showed
similar values of 21.3 A˚ for the 344W-mant ADP donor-
acceptor pair and 20.5 A˚ for the 344W-mant ATP donor-
acceptor pair. Distances were calculated to be 33.4 6 2.4 A˚
TABLE 2 Determination of FRET efﬁciencies
Nucleotide state Kd (mM) fb D (% apo)
DA (% apo)
uncorrected
DA (% apo)
corrected Efﬁciency (%) Ro (A˚) r (A˚)
(mant) ADP 8.2 6 0.02 0.53 6 0.02 81 6 5 82 6 4 76 6 4 6.4 6 0.4 21.3 33.4 6 2.4
(mant) ATP 0.84 6 0.02 0.94 6 0.01 76 6 3 58 6 4 58 6 4 23.8 6 2.3 20.5 24.9 6 2.2
Kd; dissociation constant for mant nucleotide binding to F344W-MDE; fb; fraction of mant nucleotide bound to F344W at experimental concentrations; D,
donor ﬂuorescence in the presence of unlabeled nucleotide as a percentage of the apo signal; DA uncorrected; donor ﬂuorescence in the presence of mant
nucleotide as a percentage of the apo signal; DA corrected, donor ﬂuorescence in the presence of mant nucleotide acceptor as a percentage of the apo signal
corrected for inner-ﬁlter effects and fraction of bound nucleotide; Efﬁciency, efﬁciency of FRET as determined from D and DA; R0, the distance at which
energy transfer is 50%; and r, the distance between 344W and the mant moiety in each nucleotide state.
FIGURE 3 Acrylamide quenching of F344W-MDE under apo (s), ADP
(¤), and ATP (h) conditions. F0/F was plotted against [acrylamide] and ﬁt
to the Stern-Volmer equation (Eq. 2). The resulting Stern-Volmer constants
were divided by the ﬂuorescence lifetime under each experimental condition
in the absence of acrylamide to determine the appropriate bimolecular
quenching constants (kq).
FIGURE 4 Determination of F344W-MDE afﬁnity for mant ATP and
mant ADP by steady-state titration. Association curves showing mant ADP
(¤) and mant ATP (s) binding to F344W-MDE as a function of [mant
nucleotide]. The determined Kd values (Eq. 7) indicate much tighter binding
of mant ATP (Kd ¼ 0.846 0.02 mM) to F344W-MDE as compared to mant
ADP (Kd ¼ 10.5 6 0.8 mM).
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between the 344W and mant ADP and 24.96 2.2 A˚ between
344W and mant ATP using Eq. 4, indicating an 8.5-A˚
movement between 344W and the mant moiety in the
strongly and weakly actin-bound states of the smooth-
muscle myosin ATPase cycle.
In addition to the strongly ﬂuorescent 344W residue, the
F344W-MDE contains 28 endogenous weakly ﬂuorescent
tyrosines. Although our experiments were done at an ex-
citation wavelength of 295 nm, which should produce little
or no tyrosine excitation, we controlled for the contribution
of tyrosine ﬂuorescence by subtracting emission spectra ob-
tained under identical experimental conditions of a ‘‘null-
MDE’’ mutant from our F344W-MDE emission spectra. The
null-MDE is identical to the F344W-MDE except for the
presence of a phenylalanine at position 344 and thus contains
no tryptophan residues. Our subtractions of null-MDE spec-
tra from F344W-MDE spectra conﬁrm that the tyrosines in
our MDE construct make no contribution to our FRET re-
sults (data not shown).
DISCUSSION
Interpretation of our FRET results
FRET measurements between 344W and mant nucleotide
have allowed us to compare the distance between 344W and
the mant moiety in both weakly (presence of ATP) and
strongly (presence of ADP) actin-bound states of the ATPase
cycle. Because mant nucleotide was the FRET acceptor in
our experiments it was not possible to measure this distance
in a nucleotide-free state. However, comparisons of the
FRET signal in the presence of ATP and ADP show a unique
position of the upper-50-kD subdomain of smooth-muscle
myosin, and provide the ﬁrst experimental evidence in
solution of a substantial structural change around the myosin
active site. Our results are consistent with both the structural
rearrangement of the active site predicted by Rayment et al.
(14) and the pivoting of the upper-50-kD subdomain used by
Holmes et al. (11) to ﬁt myosin ADP structures to cryo-EM
reconstructions.
Although FRET results in general should not be mis-
interpreted as giving accurate determinations of distance, our
FRET-measured distance change of 8.5 A˚ is of sufﬁcient
magnitude and certainty to show a deﬁnite distance change
between the 344W residue and mant moiety in the presence
of ADP as compared to the presence of ATP. The most
straightforward explanation of this opening is movement of
the upper-50-kD subdomain. However, it is also possible that
our FRET results reﬂect a more local rearrangement of the
short loop that contains the 344W residue, and/or that the
mant moiety is repositioned during the ATPase cycle,
contributing to the observed distance change. Even in the
case in which a combination of nucleotide repositioning and
local 344 loop movement causes the opening between the
344W residue and mant moiety in the ADP state, our results
still demonstrate a rearrangement of the core active site.
Thus, our results provide the ﬁrst evidence in solution
consistent with a movement of upper-50-kD subdomain that
FIGURE 5 Determination of the F344W-MDE-mant ADP binding and
dissociation rates. (A) Linear ﬁt to the plot of the observed rate of binding to
F344W-MDE versus mant ADP concentration gives an apparent second-
order binding rate constant of 0.79 mM1 s1. Attenuation of intrinsic
ﬂuorescence from 344W was followed as a function of time as 2 mM
F344W-MDE was rapidly mixed with 0.3–5 mM mant ADP. The nonzero
y-intercept is equal to the mant ADP release rate and is in good agreement
with the value measured experimentally by the chase experiment. The inset
shows an averaged trace composed of ﬁve stopped-ﬂow records at 2.5 mM
mant ADP. (B) Chase experiment to determine the rate of mant ADP release
from F344W-MDE. Two micromoles F344W-MDE in the presence of 10
mM mant ADP was rapidly mixed with 500 mM unlabeled ATP, and the re-
sulting attenuation of mant ﬂuorescence was followed as a function of time
(averaged data from four traces). A single exponential ﬁt of the data gives an
F344W-MDE-mant ADP dissociation rate of 6.47 6 0.10 s1. All stopped-
ﬂow experiments were performed at 25C.
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opens the myosin active site in a strongly actin-bound state
of the ATPase cycle. Such an opening may be necessary to
coordinate nucleotide hydrolysis to actin binding. We
therefore propose a model of myosin domain coordination
in which movement of the 50 kD cleft during actin binding is
communicated to the active site through a pivoting of the
upper-50-kD subdomain as the 50-kD cleft closes on actin,
effectively opening the active site and increasing the rate of
product release. Changes in the interactions and positions of
switch I and switch II upon product release would then be
communicated to the converter domain through the switch II
helix, triggering the powerstroke only after myosin has en-
tered the strongly bound state. As the power stroke is almost
certainly timed to occur when myosin is strongly bound to
actin, the necessity of such a mechanism to link product
release to actin binding is understandable.
Interpretation of our steady-state results using
unlabeled nucleotides
Our steady-state results using unlabeled ATP and ADP sug-
gest that structural changes occur during the ATPase cycle
that place the 344W residue in a different environment in
the apo, ADP, and ATP states. As no spectral shift was seen
in the presence of either nucleotide, it is likely that the at-
tenuation of ﬂuorescence was not the result of a large change
of exposure of 344W to solvent, but instead probably reﬂects
closer proximity of 344W to a charged protein side chain
capable of altering the ﬂuorescence emitted by 344W. Re-
search on mechanisms leading to ﬂuorescence quenching of
tryptophans in proteins suggests that charged residues can
inﬂuence quantum yield by stabilizing a charge-transfer state
in which the peptide bonds accept the excited electron from
tryptophan (29). Inspection of the chicken smooth-muscle
myosin amino acid structure shows several such residues,
including a string of three glutamic acid residues located at
positions 346–348, which could provide such a function.
This conclusion is supported by our quenching results, which
showed nearly identical bimolecular quenching constants for
the apo, ADP, and ATP states, respectively. Regardless of
the underlying basis for the differential quenching observed
in the ADP and ATP states, we have obtained the appropriate
donor-only signals in each state to use in determinations of
FRET efﬁciency in the presence of mant nucleotide.
Technical issues and caveats
Because the mant moiety used as our FRET acceptor absorbs
strongly at both the excitation wavelength used in our
experiments (295 nm) and at the emission maxima of the
344W tryptophan (333 nm), accurately correcting for the
substantial inner-ﬁlter effects obtained at high mant nucleo-
tide concentrations represented a difﬁculty. We avoided this
inaccuracy by performing our ﬂuorescence experiments at
nonsaturating mant nucleotide concentrations of 10 mM
mant ADP and 15 mM mant ATP. Therefore our deter-
minations of FRET efﬁciency were dependent on knowing
the fraction of protein bound to mant nucleotide, which we
calculated based on the afﬁnities of mant nucleotides for
F344W-MDE. The excellent agreement between the two
very different methods we used to determine the afﬁnity of
F344W-MDE for mant ADP afﬁnity gives us conﬁdence in
our correction for the fraction of mant ADP bound to
F344W-MDE in the FRET experiments. In the case of mant
ATP we also had excellent agreement between two different
measurements of Kd. Due to the hydrolysis of mant ATP
during each titration it was not possible to titrate with very
low concentrations of mant ATP. However, the concentra-
tion of mant ATP used in the FRET experiments (15 mM)
relative to the saturation point observed in our steady-state
titrations (.6 mM) strongly suggests that F344W-MDE was
indeed almost completely saturated.
The Kd values obtained for F344W-MDE (mant ATP, 0.8
mM; mant ADP, 8.2 mM) are in close agreement with values
we obtained for the null-MDE (mant ATP, 0.5 mM; mant
ADP, 8 mM) and Kd values determined for W29-MDE,
another single tryptophan MDE mutant protein constructed
in our lab (mant ATP, 1 mM; mant ADP, 7 mM; data not
shown). Working with smooth-muscle wild-type S1 myosin
II, Cremo and Geeves (28) obtained a Kd of 0.075 mM for
mant ADP and 16-fold higher Kd for ADP of 1.2 mM.
However, Kd values for various myosin II S1 proteins for
ADP range widely, from 0.33 mM for cardiac S1 (30) to 37
mM for Dictyostelium myosin II (31), and thus it is not
surprising that the single tryptophan-MDE mutant smooth-
muscle myosin varies from the wild-type S1 in its nucleotide
afﬁnities.
There are a number of caveats that must be addressed
regarding interpretation of our FRET data. When F344W-
MDE is combined with ATP or mant ATP, we would expect
myosin to be found in a mixture of intermediate states, with
the weakly actin-bound MATP and MADP Pi species pre-
dominating. Rate constants previously determined for the
elemental steps of ATP hydrolysis by smooth-muscle myo-
sin II suggest that the MADP Pi species should be the most
populated state, as the forward hydrolysis step is favored
over the reverse hydrolysis step and phosphate release is
rate-limiting (32). Our results in the presence of mant ATP
therefore most likely represent a mixture of weakly actin-
bound states of the myosin ATPase cycle.
Because our FRET study was done on a population of
molecules in solution, the FRET distances reﬂect average
distances between 344W and the mant moiety for the pop-
ulation. As it is a near certainty that myosin interconverts
between a wide range of conformations in each nucleotide
state (i.e., the myosin energy landscape is populated by many
variants in each nucleotide state of the ATPase cycle), our
FRET study cannot distinguish these conformations and
dynamic motions within them. In fact, conformations that are
relatively rare and thus contribute little to FRET may be
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highly important in terms of experiencing interactions that
drive myosin through the ATPase cycle. However, this ca-
veat is true of any FRET solution study and does not de-
crease the value of our results.
Finally, in calculating R0 between the 344W and mant
nucleotides we made the assumption that the orientation
factor, K2, is equal to 2/3. This implies that the 344W-mant
nucleotide FRET donor-acceptor pair are free to rotate and
thus rotational diffusion between the probes will occur after
excitation but before energy transfer takes place. Although
the possible range of K2 values is 0–4, when the 2/3 as-
sumption is made the FRET distance cannot be in error by
.35% (33). For example, if K2 was in reality 0.1 in the
presence of both mant ADP and mant ATP, the distance
change between the weakly and strongly actin-bound states
of the ATPase cycle decreases to only 6.2 A˚, still a signiﬁcant
difference. An increase in K2 would only serve to increase
the observed difference in distance between these states.
Thus it is clear that variation in K2 from the assumed 2/3
value would not signiﬁcantly affect our basic conclusion that
there is a large-scale closure between the 344W residue and
the mant moiety during the transition from the strongly
(ADP) to weakly (ATP) actin-bound states of the myosin
ATPase cycle.
Comparison to available crystal structure data
Superimposition of mant nucleotide coordinates from
Dictyostelium myosin II (4) on the chicken smooth-muscle
myosin MDE structure (2) showed a distance between the
mant moiety and 344W of 22.4 A˚, in very good agreement
with our FRET-determined distance. Distance measurements
from both the P-loop and the ribose ring of the bound nu-
cleotide to F344 or its equivalent show that little variation in
these distances occurs among nucleotide-bound myosin II
structures, most likely because these structures capture weak
actin-binding states with switch I closed and nucleotide
tightly bound.
Recently Coureux et al. (9,34) obtained chicken myosin V
structures in the absence of nucleotide or soaked with ADP
that show switch I in an open position, as well as an ADP.
BeFx structure that resembles previous myosin II struc-
tures with switch I closed. Another recent apo structure for
Dictyostelium myosin II (8), is in close agreement with the
myosin V apo structure. By comparison with the myosin II
nucleotide-bound structures the P-loop has moved closer to
the 344 position in the myosin V ADP and apo structures
(Fig. 6). Thus, the conformational state observed for smooth-
muscle myosin in the presence of ADP in this study, in
which 344W has moved further away from the nucleotide, is
likely to be unique compared to the ADP or apo structures
seen in myosin V. Although the myosin V-ADP structure
does capture switch I in an open position, the authors state
that this structure likely corresponds to a weakly ADP-bound
state of myosin V (34). In contrast, the ADP state captured in
our study is likely a tightly ADP-bound state. Rosenfeld et al.
(35) demonstrated that, unlike skeletal and Dictyostelium
myosin II, smooth-muscle myosin is capable of adopting
a unique strong actin-binding, tightly ADP-bound state, i.e.,
actin and ADP binding can be loosely coupled in smooth-
muscle myosin. They argued that the tight afﬁnity for ADP
in this state may be mediated by loop 1, which would explain
the fact that the active site in our smooth-muscle myosin
construct is open and yet binds ADP relatively tightly. A
unique strongly bound ADP state has also been observed in
smooth-muscle myosin by Whittaker et al. (36), who used
cryo-EM and helical image reconstruction to demonstrate
that ADP release generates an additional tilt of 23 of the
regulatory domain in chicken gizzard smooth-muscle myo-
sin not seen in skeletal and Dictyostelium myosin II. There-
fore, our smooth-muscle ADP FRET result may capture a
myosin state that does not exist in skeletal and Dictyostelium
myosin II isoforms.
In addition, whereas the nucleotide tends to shift along
with the P-loop in the myosin V structures, the position of
the mant attachment, the 39 carbon of the ribose ring, shows
little change relative to 344W in any of the structures. Thus,
the evidence from crystal structures suggests that movement
of the mant moiety is not the source of the distance change
in our FRET study. Therefore, the simplest interpretation of
our FRET results is that we are observing movement of the
upper-50-kD domain. The 8-A˚ movement of 344W away
from the nucleotide we observe in the presence of ADP is
consistent with the model of Holmes et al. (11), in which
FIGURE 6 Superimposition of Dictyostelium myosin II mant ADP
(1LVK.pdb (4)) with myosin V apo (1OE9.pdb (9)) and ADP structures
(1W7I.pdb (34)). The P-loop and 344W equivalents are shown in red
(myosin II mant ADP structure), green (myosin V ADP structure), and blue
(myosin V apo structure). The distance between the 344W position and the
P-loop decreases in the myosin V apo and ADP structures relative to that in
the myosin II mant ADP structure due to movement of the P-loop.
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rigid rotation of the upper-50-kD subdomain upon actin
binding serves to close the actin-binding cleft and open
switch I at the active site. The presence of ADP may stabilize
the active site in a more open conformation and/or the actin-
binding cleft in a more closed conformation in the absence
of actin. Another intriguing possibility is that a more open
active site in the ADP state is physiologically relevant in
terms of product release.
Future work
The ability of the 344W residue to indicate movement of
the upper-50-kD subdomain, which correlates to changes
between weakly and strongly actin-bound states, provides a
useful ﬂuorescent signal for use in future kinetics studies to
correlate structural rearrangements of the myosin active site
to the biochemical events of the ATPase cycle. As well, such
studies can provide a means to correlate active-site move-
ment with motions of other myosin domains that must be
coordinated to produce directed force and motion during
muscle contraction and other forms of cell motility.
We thank Kathy Trybus (University of Vermont) for her kind donation of
the wild-type MDE cDNA, and Steven Rosenfeld (University of Alabama
at Birmingham) for his generous gift of mant nucleotides. We also thank
Christopher Yengo, Art Rovner, Patty Fagnant, Marilyn van Duffelen,
Nicholas James, Scott Berbick, and Marque Moffett for their technical and
intellectual contributions to this project.
This work was supported by a grant to C.L.B. from the National Institutes
of Health, HL 63798.
REFERENCES
1. Lymn, R. W., and E. W. Taylor. 1971. Mechanism of adenosine
triphosphate hydrolysis by actomyosin. Biochemistry. 10:4617–4624.
2. Dominguez, R., Y. Freyzon, K. M. Trybus, and C. Cohen. 1998.
Crystal structure of a vertebrate smooth muscle myosin motor domain
and its complex with the essential light chain: visualization of the pre-
power stroke state. Cell. 94:559–571.
3. Houdusse, A., V. N. Kalabokis, D. Himmel, A. G. Szent-Gyorgyi, and
C. Cohen. 1999. Atomic structure of scallop myosin subfragment S1
complexed with MgADP: a novel conformation of the myosin head.
Cell. 97:459–470.
4. Bauer, C. B., P. A. Kuhlman, C. R. Bagshaw, and I. Rayment. 1997.
X-ray crystal structure and solution ﬂuorescence characterization of
Mg.29(39)-O-(N-methylanthraniloyl) nucleotides bound to the Dictyo-
stelium discoideum myosin motor domain. J. Mol. Biol. 274:394–407.
5. Fisher, A. J., C. A. Smith, J. B. Thoden, R. Smith, K. Sutoh, H. M.
Holden, and I. Rayment. 1995. X-ray structures of the myosin motor
domain of Dictyostelium discoideum complexed with MgADP.BeFx
and MgADP.AlF4. Biochemistry. 34:8960–8972.
6. Gulick, A. M., C. B. Bauer, J. B. Thoden, and I. Rayment. 1997. X-ray
structures of the MgADP, MgATPgammaS, and MgAMPPNP
complexes of the Dictyostelium discoideum myosin motor domain.
Biochemistry. 36:11619–11628.
7. Rayment, I., W. R. Rypniewski, K. Schmidt-Base, R. Smith, D. R.
Tomchick, M. M. Benning, D. A. Winkelmann, G. Wesenberg, and
H. M. Holden. 1993. Three-dimensional structure of myosin subfrag-
ment-1: a molecular motor. Science. 261:50–58.
8. Reubold, T. F., S. Eschenburg, A. Becker, F. J. Kull, and D. J.
Manstein. 2003. A structural model for actin-induced nucleotide re-
lease in myosin. Nat. Struct. Biol. 10:826–830.
9. Coureux, P. D., A. L. Wells, J. Menetrey, C. M. Yengo, C. A. Morris,
H. L. Sweeney, and A. Houdusse. 2003. A structural state of the
myosin V motor without bound nucleotide. Nature. 425:419–423.
10. Volkmann, N., G. Ouyang, K. M. Trybus, D. J. DeRosier, S. Lowey,
and D. Hanein. 2003. Myosin isoforms show unique conformations in
the actin-bound state. Proc. Natl. Acad. Sci. USA. 100:3227–3232.
11. Holmes, K. C., I. Angert, F. J. Kull, W. Jahn, and R. R. Schroder.
2003. Electron cryo-microscopy shows how strong binding of myosin
to actin releases nucleotide. Nature. 425:423–427.
12. Yengo, C. M., E. M. De La Cruz, L. R. Chrin, D. P. Gaffney 2nd, and
C. L. Berger. 2002. Actin-induced closure of the actin-binding cleft of
smooth muscle myosin. J. Biol. Chem. 277:24114–24119.
13. Conibear, P. B., C. R. Bagshaw, P. G. Fajer, M. Kovacs, and A.
Malnasi-Csizmadia. 2003. Myosin cleft movement and its coupling to
actomyosin dissociation. Nat. Struct. Biol. 10:831–835.
14. Rayment, I., H. M. Holden, M. Whittaker, C. B. Yohn, M. Lorenz,
K. C. Holmes, and R. A. Milligan. 1993. Structure of the actin-myosin
complex and its implications for muscle contraction. Science. 261:58–
65.
15. Vale, R. D. 1996. Switches, latches, and ampliﬁers: common themes of
G proteins and molecular motors. J. Cell Biol. 135:291–302.
16. Naber, N., T. J. Minehardt, S. Rice, X. Chen, J. Grammer, M. Matuska,
R. D. Vale, P. A. Kollman, R. Car, R. G. Yount, R. Cooke, and E. Pate.
2003. Closing of the nucleotide pocket of kinesin-family motors upon
binding to microtubules. Science. 300:798–801.
17. Nassar, N., G. Horn, C. Herrmann, A. Scherer, F. McCormick, and A.
Wittinghofer. 1995. The 2.2 A˚ crystal structure of the Ras-binding
domain of the serine/threonine kinase c-Raf1 in complex with Rap1A
and a GTP analogue. Nature. 375:554–560.
18. Kawashima, T., C. Berthet-Colominas, M. Wulff, S. Cusack, and R.
Leberman. 1996. The structure of the Escherichia coli EF-Tu.EF-Ts
complex at 2.5 A resolution. Nature. 379:511–518.
19. Yengo, C. M., P. M. Fagnant, L. Chrin, A. S. Rovner, and C. L. Berger.
1998. Smooth muscle myosin mutants containing a single tryptophan
reveal molecular interactions at the actin-binding interface. Proc. Natl.
Acad. Sci. USA. 95:12944–12949.
20. Laemmli, U. K. 1970. Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature. 227:680–685.
21. Edelhoch, H. 1967. Spectroscopic determination of tryptophan and
tyrosine in proteins. Biochemistry. 6:1948–1954.
22. Pardee, J. D., and J. A. Spudich. 1982. Puriﬁcation of muscle actin.
Methods Enzymol. 85 Pt. B:164–181.
23. White, H. D. 1982. Special instrumentation and techniques for kinetic
studies of contractile systems. Methods Enzymol. 85 Pt. B:698–708.
24. Valeur, B., and G. Weber. 1977. Resolution of the ﬂuorescence
excitation spectrum of indole into the 1La and 1Lb excitation bands.
Photochem. Photobiol. 25:441–444.
25. Eftink, M. R., and C. A. Ghiron. 1981. Fluorescence quenching studies
with proteins. Anal. Biochem. 114:199–227.
26. Fo¨rster, T. 1965. Delocalized excitation and excitation transfer. In
Modern Quantum Chemistry. Vol. 3, Action of Light and Organic
Crystals. O. Sinanoglu, editor. Academic Press, New York.
27. Yengo, C. M., L. R. Chrin, A. S. Rovner, and C. L. Berger. 2000.
Tryptophan 512 is sensitive to conformational changes in the rigid
relay loop of smooth muscle myosin during the MgATPase cycle.
J. Biol. Chem. 275:25481–25487.
28. Cremo, C. R., and M. A. Geeves. 1998. Interaction of actin and ADP
with the head domain of smooth muscle myosin: implications for
strain-dependent ADP release in smooth muscle. Biochemistry. 37:
1969–1978.
29. Callis, P. R., and T. Liu. 2004. Quantitative prediction of ﬂuorescence
quantum yields for tryptophan in proteins. J. Phys. Chem. B. 108:
4248–4259.
Myosin Active-Site Rearrangements 1891
Biophysical Journal 89(3) 1882–1892
30. Siemankowski, R. F., and H. D. White. 1984. Kinetics of the in-
teraction between actin, ADP, and cardiac myosin-S1. J. Biol. Chem.
259:5045–5053.
31. Ritchie, M. D., M. A. Geeves, S. K. Woodward, and D. J. Manstein.
1993. Kinetic characterization of a cytoplasmic myosin motor domain
expressed in Dictyostelium discoideum. Proc. Natl. Acad. Sci. USA.
90:8619–8623.
32. Marston, S. B., and E. W. Taylor. 1980. Comparison of the myosin and
actomyosin ATPase mechanisms of the four types of vertebrate
muscles. J. Mol. Biol. 139:573–600.
33. dos Remedios, C. G., and P. D. Moens. 1995. Fluorescence resonance
energy transfer spectroscopy is a reliable ‘‘ruler’’ for measuring
structural changes in proteins. Dispelling the problem of the unknown
orientation factor. J. Struct. Biol. 115:175–185.
34. Coureux, P. D., H. L. Sweeney, and A. Houdusse. 2004. Three myosin
V structures delineate essential features of chemo-mechanical trans-
duction. EMBO J. 23:4527–4537.
35. Rosenfeld, S. S., J. Xing, M. Whitaker, H. C. Cheung, F. Brown, A.
Wells, R. A. Milligan, and H. L. Sweeney. 2000. Kinetic and
spectroscopic evidence for three actomyosin:ADP states in smooth
muscle. J. Biol. Chem. 275:25418–25426.
36. Whittaker, M., E. M. Wilson-Kubalek, J. E. Smith, L. Faust, R. A.
Milligan, and H. L. Sweeney. 1995. A 35-A movement of smooth
muscle myosin on ADP release. Nature. 378:748–751.
1892 Robertson et al.
Biophysical Journal 89(3) 1882–1892
